Pirson, S., Gautier, M., Deroye, J., Blacher, S., Lebeau, A., Gucciardo, F., Baudin, L., Rouaud, L., Gilles, C., & Noël, A. (10 November 2022). Identification of a new partner of uPARAP/Endo180 involved in lymphangiogenesis processes [Poster presentation]. Imagine all the Vessels. |
Gucciardo, F., Lebeau, A., Pirson, S., Blacher, S., Gautier, M., & Noël, A. (01 November 2022). Mechanistical investigation of the lymphatic morphogenesis during lymphedema [Poster presentation]. Gordon Research Conference, Barga, Italy. |
Pirson, S., Gautier, M., Deroye, J., Lebeau, A., Gucciardo, F., Baudin, L., Rouaud, L., Gilles, C., & Noël, A. (30 September 2022). Identification of a new partner of uPARAP/Endo180 involved in lymphangiogenesis processes [Poster presentation]. BACR, Gand, Belgium. |
Pirson, S., Gautier, M., Deroye, J., Lebeau, A., Gucciardo, F., Baudin, L., Rouaud, L., & Noël, A. (06 September 2022). Identification of a new partner of uPARAP/Endo180 involved in lymphangiogenesis processes [Poster presentation]. Giga Day, Liège, Belgium. |
Gucciardo, F., Pirson, S., Baudin, L., Lebeau, A., & Noël, A. (22 April 2022). uPARAP/Endo180: a multifaceted protein of mesenchymal cells. Cellular and Molecular Life Sciences, 79 (5), 255. doi:10.1007/s00018-022-04249-7 |
Gucciardo, F., Pirson, S., Lebeau, A., BLACHER, S., & Noël, A. (08 April 2022). Mechanistic investigation of the lymphatic morphogenesis during cancer progression [Poster presentation]. Télévie Seminar, Liège, Belgium. |
Pirson, S., Gautier, M., Lebeau, A., Gucciardo, F., & Noël, A. (14 December 2021). Identification of a new partner of uPARAP/Endo180 involved in migration of lymphatic endothelial cells [Poster presentation]. Giga-Cancer Day. |
Gucciardo, F., Pirson, S., Lebeau, A., BLACHER, S., & Noël, A. (17 November 2021). Mechanistic investigation of the lymphatic morphogenesis during cancer progression [Poster presentation]. 9ème congrès de la Société Francaise d'Angiogenèse, Nantes, France. |
Henrotin, Y., Hick, A.-C., Labasse, A., Pelousse, F., Lemaire, J.-M., Helleputte, T., Cobraiville, E., Pirson, S., Garcia, L., & Costes, B. (April 2020). Cartilage biomarkers S-COLL2-1 and S-COLL2-1NO2 are helpful in identifying knee osteoarthritis patients at risk of disease worsening. Osteoarthritis and Cartilage, 28 (Suppl 1), 327-28. |
Montjean, R., Escaich, S., Paolini, R., Carelli, C., Pirson, S., Neutelings, T., Henrotin, Y., & Vêtu, C. (2020). REG-O3 chimeric peptide combining growth hormone and somatostatin sequences improves joint function and prevents cartilage degradation in rat model of traumatic knee osteoarthritis. PLoS ONE, 15 (4), 0231240. doi:10.1371/journal.pone.0231240 |
Hick, A.-C., Fonck, M., Costes, B., Cobraiville, E., Pirson, S., Garcia, L., Labasse, A., Vander Poelen, S., & Henrotin, Y. (2019). Serum Levels of Coll2-1, a Specific Biomarker of Cartilage Degradation, Are Not Affected by Sampling Conditions, Circadian Rhythm, and Seasonality. Cartilage, 1947603519878489. doi:10.1177/1947603519878489 |